Exchange views with medical professionals to deliver product details and to educate doctors how patient will benifit, and also to acquire clinical gap information from the medical expert and get back to the R&D teams to generate schemes for new drugs that targets unment clinical demands. and also as a member of expert team of Huapont Life Science group headquarter(HLS), to provide expert advice to R&D team and export professional information by conducting extensive literature survey; Output advices mostly involve therapeutic areas management(endometriosis, diseases related to female sex hormone deficiency, endocrine therapy for breast cancer, CDK associated with type 2 diabetes etc), unment clinical demands analysis, the perspectives of epidemiological characteristics, clinical benefits, market trends; Monitoring latest clinical trials and real-world studies outcomes and status, or post approval safety reports , for products OR therapeutic areas that is/are of great interests. To convene and organise or attend internal scientific conferences periodically to discuss product opportunities, patient characteristics, clinical outcomes and product development schemes. To liaise with PM teams periodically to collect most recent feedbacks for on-going projects, and to coordinate internal resouces to address technical issues and ensure well-progression.

Scout, assess and in-license for BIC, FIC, or modified new drugs worldwide; Seek to acquire distribution right in China mainland;Dedicated into pre-clinical study of modified new drugs indicated for either TMZ sensitive or insensitive Glioblastoma.To design, predict and synthesis candidate compounds;Worked with one of the top tier CRO to carry out in-vitro MTT assay and successfully established a TMZ resistant U87 cell line(R-U87), Successfully impanted the R-U87 into rodent brain and establish TMZ resistant CDX model in situ;Tested over 40+ compounds and combination acquired positive outcome for TMZ resistantant model, observed a significant prolong of suvival;Worked with CRO to carry out acute and long term toxicity studies

-Ex senior BD manager in CPHI (Chongqing Pharmaceutical Research Institute Co., Ltd), 4 yrs), deft in leveraging industry and internal relationship to source and develop new partners, more specifically, refers to: • Explore and establish business partnership with RSM, advanced intermediates manufacturer and technology transfer organizations to ensure a budget-saving process developing and a timely CT filing or technology transfer package delivery. • Source, Identify and introduce CDMO business with foreign biotech partner in terms of ADC (antibody-drug-conjugate) payload (MMAF) and linker contract development. • Participate in the review of generic opportunities to assess viability and drive to a prioritization decision. • Deliver detailed technical, commercial information for decision making on which generic product(s) to be developed. More specifically refers to: from perspectives of Therapeutical Area, Clinical use, Epidemiologic feature, Synthetic route and cost, and Patent information. • Draft, negotiation, execution and closing of the contracts with legal, finance, PM and other areas of CPRI, handling milestone payment issue; • Handle patent matters as a patent counsel in-house, more specifically, refers to provide IP opinion for APIs exported to global regulated markets, assist to identify novel solid forms by 2theta readouts from XRPD spectrums, communicating with key API client's legal team for further confirmation. In addition, patent drafting, prosecution and enforcement, freedom-to-operate and competitive landscape analyses, infringement matters.• Stay up to date with competitive intelligence, keeping abreast of research and development in designated filed;• Maintain and strengthen relations with key partners by arranging regular visit;• Plan and attend CPHI event hold in Frankfurt, and Shanghai to explore and expand potential business partnership.

1. Small molecular targeted anti-diabetes drug development2. Small molecular targeted anti-tumor drug development3. To develop synthetic route;4. To explore unknown reaction condition;5. To prepare a PCT application documents6. Routine management of lab7. Maintenance of LC-MS

Responsibilities: 1. Small molecular targeted drug development: To develop novel synthetic route; To explore unknown reaction and complex reaction conditions; To obtain the desired product ASAP. To ensure a stable supply of key intermediates To monitor reactions by LC-MS To seperate and purify a complex reaction mixture To develop an industrial applicable process. 2. To prepare a monthly and annually work summary; 3. To compose and translate a PCT application document; 4. LC-MS, lyophilizer daily maintenance, simple troubleshooting; 5. Procurement of reagent and instrument; 6. EHS specialist; 7. Interview and train new employees. Performances: 1.Synthesized multiple new compounds, 2. Awarded the "Best Employee of FosunPharma 2010" due to great contribution and outstanding performance in discovery and preparation of the first series of DPPIV inhibitors 3. PCT application WO2012088682 and WO2011079778 and WO2014169843.